🇫🇷
France · FR · FR:67972497
BAQSIMI 3 mg, poudre nasale en récipient unidose
ReimbursedATC H04AA01
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerAMPHASTAR FRANCE PHARMACEUTICALS
CountryFR (France)
ATC codeH04AA01
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip1334009301952911 récipient(s) unidose(s) polyéthylène polypropylèneEUR 58.95
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "67972497",
"date_amm": "2019-12-16",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/19/1406",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre",
"voies_administration": "nasale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code H04AA01.
Access this data programmatically
Query BAQSIMI 3 mg, poudre nasale en récipient unidose and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.